🇺🇸 FDA
Patent

US 10301248

Compositions and methods comprising resveratrol

granted A61KA61K2800/10A61K31/618

Quick answer

US patent 10301248 (Compositions and methods comprising resveratrol) held by Biocogent, LLC expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Biocogent, LLC
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2800/10, A61K31/618, A61K8/37